期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
辛伐他汀生物合成技术述评
1
作者 宋继国 石利平 +2 位作者 尹强 刘建锋 任强 《中国科技期刊数据库 医药》 2023年第7期5-9,共5页
本文对辛伐他汀的生物合成技术进行了评述,生产辛伐他汀的方法主要为化学合成法,发酵法和生物转化法。化学合成法受限于步骤繁多,试剂种类多消耗大,产品分离复杂等缺陷;发酵法主要采用构建的基因工程改造的土曲霉菌株并没有表现出明显... 本文对辛伐他汀的生物合成技术进行了评述,生产辛伐他汀的方法主要为化学合成法,发酵法和生物转化法。化学合成法受限于步骤繁多,试剂种类多消耗大,产品分离复杂等缺陷;发酵法主要采用构建的基因工程改造的土曲霉菌株并没有表现出明显的效果;生物转化法是利用酯酶催化的反应,主要问题是区域选择性较低、产物纯化步骤复杂。通过对辛伐他汀的生物合成可行性分析,对辛代他汀合成的重要前体物莫纳可林J的生物合成研究过程以及莫纳可林J转化为辛伐他汀的酶催化技术进行了论述,认为随着新型酰基转移生物酶技术的日趋成熟,酶催化技术会成为未来最有希望的具有大规模工业应用的辛伐他汀生产技术。 展开更多
关键词 辛伐他汀 生物合成 莫纳可林J 酶催化 酰基转移生物酶
下载PDF
NAT2*6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis 被引量:21
2
作者 Norihide Higuchi Naoko Tahara +14 位作者 Katsunori Yanagihara Kiyoyasu Fukushima Naofumi Suyama Yuichi Inoue Yoshitsugu Miyazaki Tsutomu Kobayashi Koh-ichiro Yoshiura Norio Niikawa, Chun-Yang Wen, Hajime Isomoto,Saburou Shikuwa, Katsuhisa Omagari, Yohei Mizuta, Shigeru Kohno, Kazuhiro Tsukamoto Norio Niikawa Chun-Yang Wen Hajime Isomoto Saburou Shikuwa Katsuhisa Omagari Yohei Mizuta Shigeru Kohno Kazuhiro Tsukamoto 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第45期6003-6008,共6页
AIM: To investigate an association between N -acetyltransferase 2 (NAT2 )-haplotypes/diplotypes and adverse effects in Japanese pulmonary tuberculosis patients. METHODS: We studied 100 patients with pulmonary TB treat... AIM: To investigate an association between N -acetyltransferase 2 (NAT2 )-haplotypes/diplotypes and adverse effects in Japanese pulmonary tuberculosis patients. METHODS: We studied 100 patients with pulmonary TB treated with anti-TB drugs including INH. The frequencies and distributions of single nucleotide polymorphisms, haplotypes, and diplotypes of NAT2 were determined by the PCR-restriction fragment length polymorphism method, and the results were compared between TB patients with and without adverse effect, using multivariate logistic regression analysis.RESULTS: Statistical analysis revealed that the frequency of a variant haplotype, NAT2*6A , was signifi cantly increased in TB patients with hepatotoxicity, compared with those without hepatotoxicity [P = 0.001, odds ratio (OR) = 3.535]. By contrast, the frequency of a wild-type (major) haplotype, "NAT2*4", was signif icantly lower in TB patients with hepatotoxicity than those without hepatotoxicity (P < 0.001, OR = 0.265). There was no association between NAT2-haplotypes and skin rash or eosinophilia. CONCLUSION: The present study shows that NAT2 is one of the determinants of anti-TB drug-induced hepatotoxicity. Moreover, the haplotypes, NAT2*4 and NAT2*6A, are useful new biomarkers for predicting anti- TB drug-induced hepatotoxicity. 展开更多
关键词 TUBERCULOSIS Anti-tuberculosis drugs Drug-induced hepatotoxicity NAT2-haplotype DNA-baseddiagnosis
下载PDF
HDACs,histone deacetylation and gene transcription: from molecular biology to cancer therapeutics 被引量:36
3
作者 PaolaGallinari StefaniaDiMarco +2 位作者 PhillipJones MichelePallaoro ChristianSteinkühler 《Cell Research》 SCIE CAS CSCD 2007年第3期195-211,共17页
Histone deacetylases (HDACs) and histone acetyl transferases (HATs) are two counteracting enzyme families whose enzymatic activity controls the acetylation state of protein lysine residues, notably those contained... Histone deacetylases (HDACs) and histone acetyl transferases (HATs) are two counteracting enzyme families whose enzymatic activity controls the acetylation state of protein lysine residues, notably those contained in the N-terminal extensions of the core histones. Acetylation of histones affects gene expression through its influence on chromatin conformation. In addition, several non-histone proteins are regulated in their stability or biological function by the acetylation state of specific lysine residues. HDACs intervene in a multitude of biological processes and are part of a multiprotein family in which each member has its specialized functions. In addition, HDAC activity is tightly controlled through targeted recruitment, protein-protein interactions and post-translational modifications. Control of cell cycle progression, cell survival and differentiation are among the most important roles of these enzymes. Since these processes are affected by malignant transformation, HDAC inhibitors were developed as antineoplastic drugs and are showing encouraging efficacy in cancer patients. 展开更多
关键词 histone deacetylase HISTONE post-translational modification TRANSCRIPTION histone deacetylase inhibitors protein acetylation
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部